These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28386793)

  • 1. Spinal Cord Damage in Spinocerebellar Ataxia Type 1.
    Martins CR; Martinez ARM; de Rezende TJR; Branco LMT; Pedroso JL; Barsottini OGP; Lopes-Cendes I; França MC
    Cerebellum; 2017 Aug; 16(4):792-796. PubMed ID: 28386793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal cord damage in Machado-Joseph disease.
    Fahl CN; Branco LM; Bergo FP; D'Abreu A; Lopes-Cendes I; França MC
    Cerebellum; 2015 Apr; 14(2):128-32. PubMed ID: 25370748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural signature in SCA1: clinical correlates, determinants and natural history.
    Martins Junior CR; Martinez ARM; Vasconcelos IF; de Rezende TJR; Casseb RF; Pedroso JL; Barsottini OGP; Lopes-Cendes Í; França MC
    J Neurol; 2018 Dec; 265(12):2949-2959. PubMed ID: 30324307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical Spinal Cord Degeneration in Spinocerebellar Ataxia Type 7.
    Hernandez-Castillo CR; Diaz R; Rezende TJR; Adanyeguh I; Harding IH; Mochel F; Fernandez-Ruiz J
    AJNR Am J Neuroradiol; 2021 Sep; 42(9):1735-1739. PubMed ID: 34210665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
    Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spinocerebellar ataxias type 1 and 2: comparison of clinical, electrophysiological and magnetic resonance evaluation].
    Rakowicz M; Zdzienicka E; Poniatowska R; Waliniowska E; Sułek A; Jakubowska T; Niedzielska K; Rola R; Wierzbicka A; Hoffman-Zacharska D; Głazowski C; Jakubczyk T; Niewiadomska M; Zaremba J
    Neurol Neurochir Pol; 2005; 39(4):263-275. PubMed ID: 16096942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal cord atrophy in spinocerebellar ataxia type 3 and 6 : impact on clinical disability.
    Lukas C; Hahn HK; Bellenberg B; Hellwig K; Globas C; Schimrigk SK; Köster O; Schöls L
    J Neurol; 2008 Aug; 255(8):1244-9. PubMed ID: 18506570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional Brain and Spinal Cord Volume Loss in Spinocerebellar Ataxia Type 3.
    Faber J; Schaprian T; Berkan K; Reetz K; França MC; de Rezende TJR; Hong J; Liao W; van de Warrenburg B; van Gaalen J; Durr A; Mochel F; Giunti P; Garcia-Moreno H; Schoels L; Hengel H; Synofzik M; Bender B; Oz G; Joers J; de Vries JJ; Kang JS; Timmann-Braun D; Jacobi H; Infante J; Joules R; Romanzetti S; Diedrichsen J; Schmid M; Wolz R; Klockgether T
    Mov Disord; 2021 Oct; 36(10):2273-2281. PubMed ID: 33951232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.
    Schulz JB; Borkert J; Wolf S; Schmitz-Hübsch T; Rakowicz M; Mariotti C; Schöls L; Timmann D; van de Warrenburg B; Dürr A; Pandolfo M; Kang JS; Mandly AG; Nägele T; Grisoli M; Boguslawska R; Bauer P; Klockgether T; Hauser TK
    Neuroimage; 2010 Jan; 49(1):158-68. PubMed ID: 19631275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxias.
    Della Nave R; Foresti S; Tessa C; Moretti M; Ginestroni A; Gavazzi C; Guerrini L; Salvi F; Piacentini S; Mascalchi M
    Neuroimage; 2004 Jun; 22(2):698-705. PubMed ID: 15193598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
    Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
    Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
    Reetz K; Costa AS; Mirzazade S; Lehmann A; Juzek A; Rakowicz M; Boguslawska R; Schöls L; Linnemann C; Mariotti C; Grisoli M; Dürr A; van de Warrenburg BP; Timmann D; Pandolfo M; Bauer P; Jacobi H; Hauser TK; Klockgether T; Schulz JB;
    Brain; 2013 Mar; 136(Pt 3):905-17. PubMed ID: 23423669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal cord atrophy correlates with disability in Friedreich's ataxia.
    Chevis CF; da Silva CB; D'Abreu A; Lopes-Cendes I; Cendes F; Bergo FP; França MC
    Cerebellum; 2013 Feb; 12(1):43-7. PubMed ID: 22562714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes.
    Adanyeguh IM; Perlbarg V; Henry PG; Rinaldi D; Petit E; Valabregue R; Brice A; Durr A; Mochel F
    Neuroimage Clin; 2018; 19():858-867. PubMed ID: 29922574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findings.
    Jacobi H; Hauser TK; Giunti P; Globas C; Bauer P; Schmitz-Hübsch T; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdzienicka E; Kang JS; Ratzka S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; Tezenas du Montcel S; Borkert J; Schulz JB; Klockgether T
    Cerebellum; 2012 Mar; 11(1):155-66. PubMed ID: 21701895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific cerebellar and cortical degeneration correlates with ataxia severity in spinocerebellar ataxia type 7.
    Hernandez-Castillo CR; Galvez V; Diaz R; Fernandez-Ruiz J
    Brain Imaging Behav; 2016 Mar; 10(1):252-7. PubMed ID: 25917872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinocerebellar Ataxia Type 1: One-Year Longitudinal Study to Identify Clinical and MRI Measures of Disease Progression in Patients and Presymptomatic Carriers.
    Nigri A; Sarro L; Mongelli A; Castaldo A; Porcu L; Pinardi C; Grisoli M; Ferraro S; Canafoglia L; Visani E; Bruzzone MG; Nanetti L; Taroni F; Mariotti C
    Cerebellum; 2022 Feb; 21(1):133-144. PubMed ID: 34106418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET and MRI detection of early and progressive neurodegeneration in spinocerebellar ataxia type 36.
    Aguiar P; Pardo J; Arias M; Quintáns B; Fernández-Prieto M; Martínez-Regueiro R; Pumar JM; Silva-Rodríguez J; Ruibal Á; Sobrido MJ; Cortés J
    Mov Disord; 2017 Feb; 32(2):264-273. PubMed ID: 27862279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7.
    Moriarty A; Cook A; Hunt H; Adams ME; Cipolotti L; Giunti P
    Orphanet J Rare Dis; 2016 Jun; 11(1):82. PubMed ID: 27333979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 5-Year Longitudinal Clinical and Magnetic Resonance Imaging Study in Spinocerebellar Ataxia Type 3.
    Piccinin CC; Rezende TJR; de Paiva JLR; Moysés PC; Martinez ARM; Cendes F; França MC
    Mov Disord; 2020 Sep; 35(9):1679-1684. PubMed ID: 32515873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.